GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $33,000 | +22.2% | 765 | +23.4% | 0.00% | +50.0% |
| Q1 2022 | $27,000 | +17.4% | 620 | +19.2% | 0.00% | 0.0% |
| Q4 2021 | $23,000 | +15.0% | 520 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $20,000 | -61.5% | 520 | -60.3% | 0.00% | -60.0% |
| Q2 2021 | $52,000 | -43.5% | 1,311 | -49.2% | 0.01% | -50.0% |
| Q1 2021 | $92,000 | -4.2% | 2,583 | -0.8% | 0.01% | -16.7% |
| Q4 2020 | $96,000 | -93.9% | 2,603 | -93.7% | 0.01% | -94.6% |
| Q3 2020 | $1,565,000 | -24.3% | 41,586 | -17.9% | 0.22% | -26.0% |
| Q2 2020 | $2,067,000 | +5.1% | 50,672 | -2.3% | 0.30% | -12.8% |
| Q1 2020 | $1,966,000 | -11.5% | 51,887 | +9.7% | 0.34% | +8.5% |
| Q4 2019 | $2,222,000 | +2.4% | 47,285 | -7.0% | 0.32% | +1.9% |
| Q3 2019 | $2,170,000 | +10.1% | 50,851 | +3.3% | 0.31% | +7.6% |
| Q2 2019 | $1,971,000 | +0.4% | 49,250 | +4.8% | 0.29% | -8.8% |
| Q1 2019 | $1,963,000 | +79.9% | 46,973 | +64.5% | 0.32% | -60.3% |
| Q4 2018 | $1,091,000 | – | 28,551 | – | 0.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |